Susquehanna International Group, LLP Cv Rx, Inc. Call Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2024 Feb 14, 2025	BUY	$6.95 - $15.83 $74,365 - $169,381	10,700 New	10,700 $135,000
Q2 2024 Aug 15, 2024	SELL	$6.49 - $19.2 $310,871 - $919,680	-47,900 Reduced 65.8%	24,900 $298,000
Q1 2024 May 07, 2024	BUY	$17.99 - $30.49 $327,418 - $554,918	18,200 Added 33.33%	72,800 $1.33 Million
Q4 2023 Feb 14, 2024	SELL	$11.67 - $33.01 $36,177 - $102,331	-3,100 Reduced 5.37%	54,600 $1.72 Million
Q3 2023 Nov 14, 2023	BUY	$13.56 - $18.47 $145,092 - $197,629	10,700 Added 22.77%	57,700 $875,000
Q2 2023 Aug 11, 2023	SELL	$8.57 - $15.44 $495,346 - $892,432	-57,800 Reduced 55.15%	47,000 $725,000
Q1 2023 May 16, 2023	BUY	$7.08 - $19.4 $741,984 - $2.03 Million	104,800 New	104,800 $976,000

15.4M

76.5K

6.3K

Ticker CVRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,576,200
Market Cap $254M
Description
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.